SABBY 13G CTXR 3.29.18

Company

Citius Pharmaceuticals, Inc.

Filed

March 29, 2018

Accession Number

0001535610-18-000075

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →